Home › Paa na Apektado ng Diabetes
Pag-aaral pangklinika para sa Paa na Apektado ng Diabetes na nagre-recruit sa U.S.
54 pag-aaral para sa Paa na Apektado ng Diabetes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Miami, FL8 pag-aaral
- Houston, TX7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Roanoke, VA5 pag-aaral
- St. Louis, MO5 pag-aaral
- Kendall, FL4 pag-aaral
- Vista, CA4 pag-aaral
- Columbus, OH4 pag-aaral
- Atlanta, GA4 pag-aaral
- Coral Springs, FL4 pag-aaral
- Boardman, OH3 pag-aaral
- Fresno, CA3 pag-aaral
- Doral, FL3 pag-aaral
- Tulsa, OK3 pag-aaral
- Tucson, AZ3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Pompano Beach, FL3 pag-aaral
- McAllen, TX3 pag-aaral
Ayos sa estado
- Arizona6 pag-aaral
- California15 pag-aaral
- Florida15 pag-aaral
- Georgia6 pag-aaral
- Illinois3 pag-aaral
- Louisiana4 pag-aaral
- Michigan4 pag-aaral
- Missouri3 pag-aaral
- New York6 pag-aaral
- North Carolina5 pag-aaral
- Ohio8 pag-aaral
- Oklahoma4 pag-aaral
- Pennsylvania9 pag-aaral
- Texas15 pag-aaral
- Virginia5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Total Contact Soft Cast in Diabetic Foot Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04210089a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07852338Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07364630Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Nagre-recruitPhase 4
Edad 21 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06826339Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07444593DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06104969Diabetic Foot Ulcer Imaging- Study 2
Nagre-recruit
Edad 21 hanggang 100 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03942081Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07565506Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07498218CARE-D-FOOT-Nav Pilot
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07143175Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06437028Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07632001Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07161830CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07701590WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05950659Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06938685Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
Nagre-recruit
Edad 20 hanggang 80 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT04791449Mirragen Diabetic Foot Ulcer Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06598241Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update May 19, 2026 · NCT07086443Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
Nagre-recruitMaagang Phase 1
Edad 25 hanggang 75 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT07260656Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06515093A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 31, 2026 · NCT07116174Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT05172089Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07039396Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06449638Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.